EAM Global Investors’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-13,482
Closed -$4.38M 115
2023
Q2
$4.38M Buy
+13,482
New +$3.85M 1.29% 34
2023
Q1
Sell
-7,300
Closed -$1.84M 139
2022
Q4
$1.84M Buy
+7,300
New +$1.56M 0.47% 94
2020
Q4
Sell
-16,545
Closed -$2.13M 155
2020
Q3
$2.13M Hold
16,545
0.78% 52
2020
Q2
$1.44M Sell
16,545
-11,372
-41% -$874K 0.65% 78
2020
Q1
$1.68M Buy
27,917
+11,293
+68% +$836K 0.98% 39
2019
Q4
$1.23M Sell
16,624
-9,114
-35% -$586K 0.49% 102
2019
Q3
$1.57M Hold
25,738
0.76% 63
2019
Q2
$1.56M Sell
25,738
-3,189
-11% -$172K 0.66% 66
2019
Q1
$1.64M Sell
28,927
-2,768
-9% -$150K 0.73% 54
2018
Q4
$1.34M Hold
31,695
0.73% 69
2018
Q3
$1.33M Hold
31,695
0.54% 97
2018
Q2
$1.13M Buy
+31,695
New +$1.02M 0.55% 110

Other funds holding INSP

EAM Global Investors's INSP Position: Q3 2023 in Review

EAM Global Investors sold out of Inspire Medical Systems (INSP) in Q3 2023, closing a stake of 13,482 shares — an estimated $4.38M sold.

EAM Global Investors first reported a position in INSP in Q2 2018 and held it in 12 quarters. The position peaked at $4.38M in Q2 2023. 364 funds tracked by Wall St. Rank hold INSP as of Q3 2023.

  • EAM Global Investors reported no remaining Inspire Medical Systems position as of Q3 2023 after selling out during the quarter.
  • EAM Global Investors sold 13,482 Inspire Medical Systems shares in Q3 2023, an estimated $4.38M.
  • EAM Global Investors first reported a position in Inspire Medical Systems in Q2 2018 and held it in 12 quarters.
  • EAM Global Investors's Inspire Medical Systems position peaked at $4.38M in Q2 2023.
  • 364 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q3 2023.

Based on EAM Global Investors's 13F filing for Q3 2023, filed 13 Nov 2023.